Viewing Study NCT03109093


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2026-01-04 @ 3:46 AM
Study NCT ID: NCT03109093
Status: COMPLETED
Last Update Posted: 2023-03-21
First Post: 2017-03-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Blinatumomab in Adult Patients With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia
Sponsor: Goethe University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None ALL, Recurrent, Adult View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ALL View
None acute lymphoblastic leukemia View
None MRD positive View
None minimal residual disease View
None blinatumomab View